Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective/Parallel Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme

NCT00191828 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00191828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00191828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective/Parallel Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2003
Completion date
August 31, 2005
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

weight gain